01 · Rally
Rally, foster, and invest in the local cell & gene therapy community in North America.
G-Rex® Grant Program
A better business model
The G-Rex® Grant Program is a $42,000,000 initiative undertaken by ScaleReady, in collaboration with Wilson Wolf, Bio-Techne, and CellReady to benefit the cell and gene-modified cell therapy community.
The G-Rex® Grant Program is unique and unlike any other grant program. G-Rex® Grant Recipients will not be burdened with inflexible timelines, bureaucratic constraints, micromanagement, or invasive oversight.
The initiative
Program Mission
The G-Rex® Grant Program is a transformational initiative designed to benefit the cell & gene therapy community in the following ways:
-
Enhance company valuation by expediting and reducing cost on the path to meaningful clinical data.
-
Quickly and inexpensively implement an optimized G-Rex® centric manufacturing platform that is suitable for each stage of the path to commercial drug production.
-
Establish a seamless link, via G-Rex® platform continuity, between the research labs, process development labs, and the GMP manufacturing center to enable faster translation of new therapies into the clinic.
-
Increase patient access to cell gene modified cell therapies by making significant reductions in process complexity.
-
Increase the value of academic institution’s technology by allowing licensors to save valuable time and money by inheriting an expeditious pathway to clinical inflection points.
The G-Rex® Grant Program is intended to be simple, flexible, and easily accessible from initiation through completion. The G-Rex® Grant Program will be successful due to a partnership based on mutual trust, respect, and understanding.
The purpose of the G-Rex® Grant Program is to provide interested academic and commercial institutions engaged in pre-clinical research, process development, and/or cGMP manufacture of cell and gene-modified cell therapies (the “Recipient”) with the devices, reagents, and operational know-how to:
- Implement a highly efficient G-Rex® based cell manufacturing platform and/or
- Optimize an existing G-Rex® based cell manufacturing platform quickly and at low cost.
Measurable Impact
G-Rex® Grant Program Impact Stats
$42,449,000
Total grant funds ($)
Devices, reagents, services, consulting
304
grants awarded
Academic + commercial investigators
Distribution
By Cell Type
Distribution
By Geography
Distribution
By Deliverable
Recipients in the news
A glimpse into some of the programs we’ve backed so far
ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics
Learn More
ScaleReady announces the inaugural G-Rex® Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine
Learn More
ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics
Learn More
ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape
Learn More
ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. Klebanoff
Learn More
ScaleReady announces a G-Rex® Grant has been awarded to Dr. Eric Tran of the Earle A. Chiles Research Institute
Learn More
ScaleReady announces a G-Rex® Grant has been awarded to LIfT Biosciences
Learn More
ScaleReady announces a G-Rex® Grant has been awarded to Luminary Therapeutics
Learn More
ScaleReady announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy
Learn More
ScaleReady awards a G-Rex® Grant to Moonlight Bio
Learn More
ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics
Learn More
ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio
Learn More
ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.
Learn More
ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy
Learn More
ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA)
Learn More
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
Learn More
ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering
Learn More
ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine
Learn More
ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory
Learn More
ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California
Learn More
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National Hospital
Learn MoreThe program at a glance
Key Benefits & Eligibility Requirements
Award range
$5K to $300K
Each recipient receives between $5,000 and $300,000 worth of materials and services, along with free consulting support from ScaleReady G-Rex® Optimization Specialists to any academic or commercial institution that meets the criteria.
Collaboration period: Up to 18-months, extendable upon mutual agreement by the parties.
Eligibility
Academics and commercial teams working in CGT
To be eligible for the G-Rex® Grant Program, a Recipient must satisfy the following criteria:
- Be engaged in research and development of cell and gene-modified cell therapies based on or derived from T cells, NK cells, HSCs, or the like.
- Be working towards, or have, an existing Investigational New Drug (IND) application.
- Be interested in quickly establishing an optimized cGMP manufacturing process at low cost with minimal investment required.
What's included
Devices · reagents · services
Under the G-Rex® Grant Program, ScaleReady will provide the most appropriate combination of devices, reagents, and consulting support as follows:
- G-Rex® devices including G-Rex® well plates, G-Rex® bioreactors (including closed system models), and the GatheRex® Cell Harvest Pump
- G-Rex® ancillary products
- RUO and GMP Reagents
- RUO and GMP cell culture media
- TcBuster® non-viral (transposition) gene editing technology
- G-Rex® Optimization Services
- Technical Application Support
- Marketing Support
- Process Development and Manufacturing Services and Consultation
How to get started
Application & Award Process
The application process for a G-Rex® Grant is intended to be very easy and will be initiated by a simple form that will lead to a deeper dialogue with ScaleReady to help hone the application to a form suitable for receipt of a G-Rex® Grant.
Apply
G-Rex® Grants will be awarded to applicants that provide ScaleReady with:
- A compelling overview of why a G-Rex® Grant would be beneficial.
- A strong willingness to interact with ScaleReady to achieve program goals.
- Confidence that the recipient has wherewithal in program management.
- The collaborative nature of the applicant.
- Provision of a well understood set of G-Rex® Grant deliverables
Award
Upon G-Rex® Grant approval, ScaleReady will provide a high-level Non-Binding Memorandum of Understanding to the Recipient indicating the loosely agreed upon goals, estimated timelines, deliverables, actions, and respective responsibilities that were identified in the discovery phase.
Of importance, the Non-Binding Memorandum of Understanding is a guideline document only
The relationship between a G-Rex® Grant Recipient and ScaleReady is based entirely on mutual trust and understanding that flexibility will be needed to reach the Recipient's program goals.
During the Collaboration Period, the Recipient and ScaleReady will work openly and collaboratively to achieve the mutually agreed upon outcomes of the G-Rex® Grant.
Collaborate
Upon G-Rex® Grant approval, ScaleReady will provide a high-level Non-Binding Memorandum of Understanding to the Recipient indicating the loosely agreed upon goals, estimated timelines, deliverables, actions, and respective responsibilities that were identified in the discovery phase.
Of importance, the Non-Binding Memorandum of Understanding is a guideline document only
The relationship between a G-Rex® Grant Recipient and ScaleReady is based entirely on mutual trust and understanding that flexibility will be needed to reach the Recipient's program goals.
During the Collaboration Period, the Recipient and ScaleReady will work openly and collaboratively to achieve the mutually agreed upon outcomes of the G-Rex® Grant.
Deliver
During the Collaboration Period, the G-Rex® Grant Recipient and ScaleReady will work together to meet the Recipient's program goals, which will typically include creating a process and data package sufficient:
- To be included in the CMC section of an applicable IND(s), or
- Used to support further research or collaborative efforts in the Recipient institution.
Grant Partner Ecosystem
G-Rex® Grant Partner Exclusive Offers
ScaleReady has enlisted a legion of like-minded collaborators to bring additional value to help our G-Rex® Grant Recipients save time and money. All G-Rex® Grant Recipients will be provided a catalogue of exclusive offers from our official G-Rex® Grant Partners
Official partnerAccellix
Flow Cytometry
Exclusive offer on automated flow cytometry instruments
Supports automated cell analysis during process development and manufacturing. Currently part of CellReady's analytical technology suite.
Official partnerAldevron
Gene delivery and genome editing
Exclusive savings on research-use-only and GMP plasmid DNA, Nanoplasmid™ vectors, nucleases, and enzymes
Provides critical materials for gene delivery and genome-editing workflows.
Official partnerApplied Cells
Cell isolation
Exclusive savings on MARS® Bar Instrument
Cell isolation technology for preparing cells upstream of G-Rex® expansion. Read our manuscript here.
Official partnerBiolife Solutions
Biopreservation
Exclusive savings on CryoStor® media, CellSeal® Cryogenic Vials, and other fill-finish and biopreservation products and services
Supports best-in-class final-product formulation, fill-finish, cryopreservation, storage, and thaw.
Official partnerBluecord
CGT software
Exclusive offer on cell and gene therapy software
Purpose-built support for quality assurance, quality control, manufacturing, and inventory management.
Official partnerDiscovery Life Sciences
Starting material
Exclusive savings on research-use-only and GMP AllCells® products
Available products include fresh leukopaks, fresh mobilized leukopaks, and fresh bone marrow.
Official partnerMaxCyte
Non-viral gene delivery
Exclusive offer on the ExPERT GTx™ Electroporation Instrument
Supports a closed, sterile fluid path to G-Rex® bioreactors, helping streamline non-viral gene delivery within the manufacturing process.
Official partnerRose Biomedical
Starting material
Exclusive savings on fresh and cryopreserved starting material
Available products include fresh leukopaks, cryopreserved peripheral blood mononuclear cells, and more. Rose Biomedical currently supplies CellReady with healthy donor- and patient-derived apheresis for the development of G-CAR-T™.
Official partnerSTEMCELL Technologies
Cell activation
Exclusive offer on GMP ImmunoCult™ T Cell Activators
Supports T-cell activation within GMP manufacturing workflows. See their poster/abstract on performance in G-Rex®.
Official partnerTakara
Transduction enhancers
Exclusive savings on RetroNectin® Pro and selected Lenti-X products
RetroNectin® coating enables simultaneous T-cell stimulation and CAR gene transduction directly in G-Rex®. A Stanford Medicine-led study demonstrated efficient static retroviral transduction in RetroNectin®-coated G-Rex® bioreactors without spinoculation. Read the Stanford paper.
Official partnerThermo Scientific
Incubation
Special pricing on Thermo Scientific™ Heracell™ VIOS™ 250i incubators and CultiMaxx™ Shelving
Incubation infrastructure configured to support high-yield, high-quality G-Rex®-based manufacturing.
Official partnerVector Biomed
Quality lentivirus
Exclusive savings on GMP lentiviral vector (LVV)
Supports viral gene delivery for engineered cell therapy programs. VBM is currently the preferred LVV supplier to CellReady, our G-Rex® CDMO.
Exclusive Partner Offers for Grant Recipients
If you’ve been awarded a G-Rex® Grant, you can redeem exclusive partner discounts and resources using the redemption form.
Redeem Partner OffersProgram · 2026 initiative
The G-Rex® Grant Tour 2026.
The G-Rex® Grant Program has resulted in a powerful coalition of individuals and organizations working to bring hope to cancer, autoimmune and rare disease patients through adoptive cell and gene therapy. In 2026, ScaleReady and the Emily Whitehead Foundation will co-produce a series of events to:
02 · Collaborate
Promote transparency and collaboration among like-minded individuals and organizations working towards a common goal.
03 · Catalyze
Catalyze scientific and clinical progress through a shared sense of duty to the patients we all serve.
04 · Spotlight
Spotlight the breadth of diverse innovative cell and gene therapy approaches
Houston, TX · Jan 21, 2026 Houston, TX · Jan 21, 2026 
Houston, TX · Jan 21, 2026 Dr. Ann Leen · Baylor College of Medicine Houston, TX · Jan 21, 2026 
San Francisco, CA · Mar 27, 2026 Boston, MA · May 11, 2026 Boston, MA · May 11, 2026 Boston, MA · May 11, 2026 
Los Angeles, CA · Aug 20, 2026 Los Angeles, CA · Aug 20, 2026 Los Angeles, CA · Aug 20, 2026 Los Angeles, CA · Aug 20, 2026
Ready to talk?
Are you ready to scale?
Let's talk more about how ScaleReady can advance your cell & gene therapy research and manufacturing with ingenious efficiency. Every conversation starts with your program, not our catalog.
